A kind of lung cancer miRNA detection kit and the application of miRNA thereof

A detection kit and technology for lung cancer, applied in the biological field, can solve the problems of inability to meet the needs of real-time detection of scattered specimens, limited specificity and sensitivity, high cost and price, etc., and achieve fast and convenient detection, wide application range and low cost. Effect

Active Publication Date: 2016-10-05
UNIMED BIOTECH SHANGHAI CO LTD
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The content of miRNA in serum is much lower than that in tissues, so a very sensitive and specific detection method is required; and because of the short sequence of miRNA primers, primer design is difficult, and no targeted software can be used directly, so both primers and systems need to be screened and tested. optimization process
At present, chip technology is generally used for high-throughput screening of miRNA, which has high cost, limited specificity and sensitivity, and cannot meet the needs of real-time detection of scattered samples; real-time detection of a small number of miRNAs mostly uses Taqman probe method, and some of them have been commercialized Kit products, but the cost and selling price are high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of lung cancer miRNA detection kit and the application of miRNA thereof
  • A kind of lung cancer miRNA detection kit and the application of miRNA thereof
  • A kind of lung cancer miRNA detection kit and the application of miRNA thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] 1. The composition of the kit.

[0025] The lung cancer miRNA detection kit of this embodiment includes reagents for preparing a reverse transcription reaction system, reagents for preparing a PCR system, and reagents for preparing an internal reference system.

[0026] 1. Internal reference system:

[0027] The reagents used to prepare the internal reference system include the internal reference miRNA-39 solution and the forward primer solution for miR-39. The internal reference miRNA-39 solution is cel-miR-39 (Accession Number: AJ487564) solution, synthesized by Yingwei Jieji (Shanghai) Trading Co., Ltd., encapsulated in a vial, the prepared concentration is 20 μM, a total of 10 μl, used The concentration is 0.2 μM. The forward primer solution for miR-39 is packaged in a vial with a volume of 100 μl and a concentration of 2 μM. As shown in Table 1.

[0028] Table 1 Component list of internal reference system

[0029] components

volume

use concent...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
volumeaaaaaaaaaa
volumeaaaaaaaaaa
Login to view more

Abstract

The invention relates to a combination of miR-21, miR-24, miR-125b and miR-126 used as a lung cancer molecular marker, relates to application of the combination of miR-21, miR-24, miR-125b, miR-126 and miR-39 to the preparation of miRNA detection kit for lung cancers, and relates to a miRNA detection kit for the lung cancer. An RCR reaction system comprises positive primers and a reverse universal primer aiming at miR-21, miR-24, miR-125b and miR-126; an internal reference system comprises an internal reference miRNA-39 and a positive primer aiming at miR-39; a nucleotide sequence of the positive primer aiming at r miR-21 is shown in SEQ ID No.1; a nucleotide sequence of the positive primer aiming at miR-24 is shown in SEQ ID No.2; a nucleotide sequence of the positive primer aiming at miR-125b is shown in SEQ ID No.3; a nucleotide sequence of the positive primer aiming at miR-126 is shown in SEQ ID No.4; a nucleotide sequence of the positive primer aiming at miR-39 is shown in SEQ ID No.5; a nucleotide sequence of the reverse universal primer is shown in SEQ ID No.6. The miRNA detection kit for lung cancer is high in detection speed, convenient and high in correction rate and can assist in early diagnosis of lung cancer.

Description

technical field [0001] The invention relates to a miRNA detection product and the application of miR-21, miR-24, miR-125b and miR-126 as lung cancer molecular markers, and belongs to the field of biotechnology. Background technique [0002] About 1.3 million people die from lung cancer every year in the world, accounting for about 1 / 3 of all cancer deaths in the world. In my country, the number of deaths due to lung cancer exceeds 20% of the number of deaths due to tumors. Lung cancer patients are mostly in the middle and late stage when they have symptoms, and their 5-year survival rate is about 15%. If patients can be diagnosed in the early stage of lung cancer, their survival rate will be greatly improved. The occurrence and development of lung cancer is a process involving multiple genes, and the study of its molecular mechanism has positive significance for clinical diagnosis. Studies have found that microRNA (microRNA, miRNA) is related to the occurrence of various t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/68
CPCC12Q1/6886C12Q2600/158C12Q2600/178
Inventor 赵新泰王明唐娟娟
Owner UNIMED BIOTECH SHANGHAI CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products